#分享美股交易赢英伟达股票

The shift in the U.S. stock market style, healthcare defensive stocks favored by the market

In the sharp decline of the U.S. stock market on Friday, Johnson & Johnson closed at $232.770, up 2.02% from the previous trading day, achieving a rebound against the market trend. Today’s opening price was $230.000, with a high of $235.215, a low of $229.000, and a total market capitalization of $560.33B. Recently, Johnson & Johnson’s stock performance has been stable, with significant gains since the beginning of the year, demonstrating strong risk resistance and market appeal. The saying “don’t put all your eggs in one basket” applies; while allocating AI technology stocks, investors can also allocate some high-quality defensive healthcare stocks to hedge risks.

‌Technical Indicator Analysis‌

‌Trend and Moving Averages‌:

Johnson & Johnson’s stock price has recently been trading above the 30-day moving average (around $230), indicating a short-term upward trend; the 200-day moving average (far below the current price) remains upward, maintaining a long-term bullish trend.

‌RSI Indicator‌:

RSI reading is about 55-60, in a neutral to slightly bullish zone, indicating the stock is neither overbought nor oversold, with short-term momentum balanced and slightly bullish.

‌MACD Indicator‌:

The MACD histogram is positive, with the fast line above the slow line, showing short-term bullish dominance, but the histogram length has not significantly expanded, suggesting upward momentum needs further strengthening.

‌Trading Volume‌:

Recent trading volume has fluctuated but remains at a relatively high level overall, indicating high market attention to Johnson & Johnson and active capital participation.

‌Key Support and Resistance Levels‌

‌Support Levels‌:

‌First support at $230‌: the position of the 30-day moving average; a break below may lead to a decline toward $228 (the lower edge of the recent consolidation platform);

‌Strong support at $225‌: psychological level + previous low; a break below could open a larger downside space, but the probability is low.

‌Resistance Levels‌:

‌First resistance at $235‌: today’s high, also the primary resistance for short-term rebound;

‌Core resistance at $240‌: near the historical high, a breakthrough would confirm a new upward trend, targeting $250.

‌Market Outlook‌

‌Short-term‌:

Johnson & Johnson’s stock price may continue to fluctuate between $230 and $235 in the short term, with attention to volume changes and market sentiment. A volume breakout above $235 could challenge $240; a fall below $230 may test the $228 support.

‌Mid- to Long-term‌:

As a leader in the global healthcare sector, Johnson & Johnson’s diversified business (balanced development of innovative drugs and medical technology) provides strong risk resistance. The company’s recent performance has been stable, with ongoing increased R&D investment, and future growth potential is promising. Analysts generally have a positive outlook, with target prices mostly above $240, offering about a 3% upside from the current price.

‌Trading Recommendations‌

‌Stock Traders‌:

‌Aggressive Strategy‌: If the stock pulls back to around $230, consider buying lightly with a target of $235–$240, and set a stop-loss below $228;

‌Conservative Strategy‌: Wait for volume breakout above $235 before entering, to avoid being shaken out during consolidation.

‌Options Traders‌:

Consider buying call options near $230 (strike price $235, expiration before June 20), or selling put options at $230 to collect premiums, profiting from volatility convergence.